Myocardial Perfusion Imaging (MPI): A Patient-Friendly Explanation

Introduction

Myocardial Perfusion Imaging (MPI) is a non-invasive test used to evaluate blood flow to the heart muscle (myocardium). It helps identify areas with poor circulation, which can indicate coronary artery disease (CAD) or assess the effectiveness of treatments like stents or bypass surgery.

Why is MPI Important?

MPI is essential for detecting and monitoring: - Coronary artery disease (CAD) – Blocked or narrowed arteries - Heart attack (myocardial infarction) risks – Identifying high-risk areas - Heart function – Assessing how well the heart pumps blood - Treatment effectiveness – Gauging improvements after medical procedures

How is MPI Performed?

MPI is done in two phases: 1. Rest Phase – A tracer is injected into a vein while the patient is resting. A special camera captures images of blood flow in the heart. 2. Stress Phase – The patient is asked to exercise or is given medication to simulate stress on the heart. Another dose of tracer is injected, and images are taken again.

This allows doctors to compare blood flow at rest and under stress conditions.

What are the Common Test Results?

  • Normal MPI – Adequate blood flow to the heart.
  • Abnormal MPI – Indications of reduced blood flow, possibly due to artery blockages or past heart damage.

Risks and Considerations

  • MPI is generally safe but carries minor risks such as allergic reactions to the tracer or temporary discomfort.
  • If stress medication is used, it may cause short-term dizziness or chest pain.

Conclusion

MPI is a powerful tool for diagnosing heart conditions early and planning the best course of treatment. If recommended by your doctor, it can provide critical insight into your heart’s health.

Source recommendations

1. American College of Cardiology/American Heart Association Guidelines for the Clinical Use of Cardiac Radionuclide Imaging

  1. https://pubmed.ncbi.nlm.nih.gov/14522503/
  2. https://www.ahajournals.org/doi/10.1161/01.cir.0000080946.42225.4d
  3. https://www.jacc.org/doi/abs/10.1016/j.jacc.2003.08.011
  4. https://www.jtcvs.org/article/S0022-5223(18)33502-5/fulltext
  5. https://www.jacc.org/doi/10.1016/j.jacc.2003.08.011

2. European Society of Cardiology Guidelines on Chronic Coronary Syndromes

  1. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Chronic-Coronary-Syndromes
  2. https://academic.oup.com/eurheartj/article/45/36/3415/7743115
  3. https://pubmed.ncbi.nlm.nih.gov/39210710/
  4. https://academic.oup.com/eurheartj/article/41/3/407/5556137
  5. https://pubmed.ncbi.nlm.nih.gov/31504439/

Our advantages:

patient2376100
Best practices from USA, EU and Japan
Our answers to your questions are based on the clinical recommendations of countries with the most developed healthcare systems in the field of cardiology in the USA, the EU and Japan.
prescription18648039
Always up-to-date information
On a daily basis, we monitor for you all new scientific research publications in leading scientific journals on medical issues of interest to you.
We monitor all innovations and changes in the field of cardiac disease treatment on a daily basis.
fvfflf7q
Get second opinion
Here you can learn everything that even your doctor may not know about cardiology (if he does not speak English and he does not read 117 leading medical journals on cardiology every month).
1xr4duup
The most comprehensive and up-to-date collection of free cardiology materials
Our website contains the most comprehensive and up-to-date collection of free cardiology materials in your country.
Every 3-5 years, half of the scientific approaches to treatment in the field of cardiology are reviewed as a result of specialized scientific discoveries. With us, you don't have to wait these years to learn about the best ways to treat you and your loved ones.
arrow
Please register in order to receive information regarding possible complications and new approaches to treatment of cardiovascular diseases via email in our Newsletters.
arrow